An international research collaboration conducting a comprehensive review of studies from across the globe has reaffirmed that magnesium sulfate, a medication widely used during pregnancy, significantly reduces the risk of cerebral palsy and death for very preterm babies.
This article was originally published on MedicalXpress.com